Matica Biotechnology and NCTM Forge Partnership to Support Cell and Gene Therapy Innovation
Matica Biotechnology, a leading CDMO specializing in cell and gene therapies (CGT), has announced a strategic partnership with the National Center for Therapeutics Manufacturing (NCTM), a part of the Texas A&M Engineering Experiment Station. This collaboration is designed to deliver a fully integrated service platform that supports CGT developers at every stage—from early research and IND-enabling studies to clinical trials and eventual commercialization. By leveraging NCTM’s strengths in early-stage research and development alongside Matica Bio’s expertise in advanced manufacturing and regulatory strategy, the partnership provides a streamlined pathway for innovators in the CGT field. Located in College Station, Texas, this joint initiative is set to become a central hub for accelerating therapeutic breakthroughs in the rapidly evolving CGT landscape.
Matica Biotechnology and NCTM Forge Partnership to Support Cell and Gene Therapy Innovation